Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota

• Auteurs principaux: Sa Yang (Auteur), Shijie Cao (Auteur), Congyu Li (Auteur), Jichao Zhang (Auteur), Chang Liu (Auteur), Feng Qiu (Auteur), Ning Kang (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem in many countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD. Berberrubine (BRB) is one of the main active metabolites of BBR, which shows significant anti-obesity and antihypoglycemic effects. Ho...